▎药明康德内容团队编辑（来源：良渚实验室）近日，良渚实验室张进团队与中国科学院动物研究所宋默识研究组合作，在Circulation Research杂志在线发表了题为 “CAR-macrophage therapy alleviates ...

近日，北京朝阳医院麻醉科副主任医师王佳琬（第一作者）参与由中国科学院动物研究所、北京干细胞与再生医学研究院、浙江大学、首都医科大学附属北京朝阳医院、北京大学等机构合作的研究，在Circulation ...

缺血性心脏病作为全球范围内导致人类死亡与残疾的重大诱因之一，其治疗方案的优化显得尤为重要。经皮冠状动脉介入治疗（PCI）与静脉溶栓治疗，作为心肌梗死后的标准疗法，虽已广泛应用，但治疗过程中重新引入的新鲜血液往往会诱发额外的心肌细胞死亡，这极大地限制了 ...

在Circulation Research杂志在线发表了题为 “CAR-macrophage therapy alleviates myocardial ischemia-reperfusion injury”的文章。该研究首次报道了靶向嵌合抗原受体巨噬 ...

During CPB, ischemia-reperfusion injury to the heart is well documented and felt to be a major cause of postbypass low cardiac output syndrome. Both systolic and diastolic myocardial dysfunction ...

Considering taking supplements to treat ischemia reperfusion injury? Below is a list of common natural remedies used to treat or reduce the symptoms of ischemia reperfusion injury. Follow the ...

Previous studies have demonstrated that HS ameliorates myocardial ischemia/reperfusion (I/R) injury. Also, the differentially expressed proteins between HS and I/R groups were shown to be ...

Cardiomyopathy is characterized by myocardial fibrosis and myocyte ... The cardioprotective benefits of carvedilol in ischemia-reperfusion injury are likely due to multiple mechanisms of action ...

thereby attenuating myocardial injury and improving clinical prognosis in patients with STEMI,” said Jing Chen, MD (Renmin Hospital of Wuhan University, China), who presented the findings today at TCT ...

who explored the capacity of epicatechin to reduce short-and long-term ischemia-reperfusion myocardial injury. Epicatechin (1 mg/kg) pre-treatment was administered daily via oral gavage to rodents ...